The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Preliminary Considerations Regarding Federal Investments in Vaccine Purchase and Immunization Services: Interim Report on Immunization Finance Policies and Practices
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole. Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page R5
Preliminary Considerations Regarding Federal Investments in Vaccine Purchase and Immunization Services: Interim Report on Immunization Finance Policies and Practices
Contents
SUMMARY
1
INTRODUCTION
2
THE CARRYOVER ISSUE IN SECTION 317 EXPENDITURES
5
THE IMPACT OF THE STATE CHILDREN'S HEALTH INSURANCE PROGRAM
7
NEXT STEPS
9
REFERENCES
11
NOTES
12
APPENDIXES
14
Table 1
Annual Awards and Expenditures of Section 317 Direct Assistance (DA Vaccine Purchase Funds (in millions),
15
Table 2
Annual Awards and Expenditures of Section 317 Financial Assistance (FA) Immunization Program Funds (in millions),
16
Figure 1
Amount of New Funding Awarded as Section 317 Direct Assistance (DA) and Financial Assistance (FA), 1990–1999,
17
Figure 2
Amount of Total Annual Awards of Section 317 Funds, Direct Assistance (DA) and Financial Assistance (FA), 1990–1999,
17
Figure 3
Section 317 Grant Allocations from CDC to State and Local Immunization Programs, 1988–1999,
18
COMMITTEE BIOGRAPHIES
19